Back to Ovarian Cancer

NCT01421095

NCT01421095
Active, Not Recruiting Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You must have had your first menstrual period at some point (even if periods have stopped since)
  • You have been diagnosed with cancer
  • You have previously received treatment that may have affected your ovaries, such as chemotherapy, radiation to the pelvis or whole body, or removal of one ovary
  • It has been at least 1 year since you finished the treatment that may have affected your ovaries
  • You still have your uterus (womb)
  • You still have at least one ovary

Who may not be able to join:

  • You may not be able to join if your cancer is the type that is fuelled by the hormone estrogen (known as "estrogen receptor positive" cancer)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Active, Not Recruiting
Phase
Not Applicable
Sponsor
University of California, San Diego
Registry
clinicaltrials_gov
Start date
1 January 2011
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Return of menses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov